Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Biogen Idec
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
Study to Evaluate BIIB059 in CLE with or without SLE
The primary objective of the study is to evaluate the efficacy of BIIB059 in reducing skin disease activity in participants with systemic lupus erythematosus (SLE) (Part A), and in participants with a...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Ltd
Update Il y a 4 ans
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Finding Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BG9924 When Given in Combination With Methotrexate to Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional DMARD Therapy
To evaluate the efficacy of 5 dose regimens of BG9924 when administered in combination with MTX to subjects with active RA who have had an inadequate response to conventional DMARD therapy. The prima...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
The primary objective of the study is to evaluate the effect of BG00012 on lymphocyte subset counts during the first year of treatment in subjects with RRMS.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
A study to compare the safety and efficacy of BIIB033 to a placebo in patients with first episode of loss of vision due to acute inflammation in the optic nerve
The primary objective of the study is to evaluate the efficacy of BIIB033 in subjects with their first episode of unilateral AON.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Biogen Idec
Update Il y a 4 ans
High-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on Natalizumab
• To explore the effects of administering high-dose corticosteroids to subjects who develop Progressive Multifocal Leukoencephalopathywhile on natalizumab • To characterize the evolution of Immune Rec...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
A study of BG00012 on MRI lesions and Pharmacokinetics in children from 10 to less than 18 years old with a type of Multiple Sclerosis called 'Relapsing, Remitting Multiple Sclerosis'
The primary objective of this study is to evaluate the effect of BG00012 on brain MRI lesions in paediatric subjects with RRMS
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
A Study to assess the safety and tolerability of ISIS 396443 in participants with spinal muscular atrophy (SMA)
The primary objective of Part 1 the study is to assess the safety and tolerability of ISIS 396443 in participants with SMA who are not eligible to participate in the clinical studies ISIS 396443-CS3B ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
A Clinical Study of the Safety and Efficacy of Natalizumab in Acute Ischemic Stroke Un ensayo clínico de la seguridad y eficacia de Natalizumab en el accidente cerebrovascular isquémico agudo
The primary objective of the study is to assess the effects of natalizumab versus placebo in acute ischemic stroke on clinical measures of independence and activities of daily life El objetivo p...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Research Limited
Update Il y a 4 ans
Long-Term Prolonged-Release Fampridine Treatment and Quality of Life
The primary objective of the study is to assess the effect of long-term treatment with prolonged-release fampridine 10 mg twice daily on the physical component scale (PCS) of the Short Form (36) Healt...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Italia S.r.l
Update Il y a 4 ans
Study for the satisfaction assessement of the treatment with Plegridy in patient with Multiple Sclerosis Studio per la valutazione della soddisfazione dei pazienti con Sclerosi Multipla all'utilizzo del farmaco Plegridy
The primary objective of the study is to investigate whether Peg-IFN beta-1a improves patients’ satisfaction in RRMS subjects unsatisfied with other injectable subcutaneous Interferons, as measured by...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
5
6
7
8
9
Next